India’s first mRNA vaccine candidate, developed by Pune-based Gennova in collaboration with US HDT Bio, received approval for human trials to determine if it is safe and produces a protective immune response against the coronavirus disease (Covid-19). The Indian drug regulator’s Subject Matter Expert Committee recommended that the candidate vaccine, …
Read More »FDA Reports Facial Paralysis in 4 Volunteers for Pfizer’s Covid-19 Vaccine
A new report from U.S. Food and Drug Administration (FDA) regulators revealed that four volunteers for Pfizer’s COVID-19 experimental vaccine developed Bell’s palsy after receiving injections of the vaccine, according to reports from the media. Bell’s palsy is a condition that causes temporary paralysis of the muscles in the face. …
Read More »US Panel Supports Widespread Use of Pfizer Covid-19 Vaccine
A U.S. government advisory panel endorsed the widespread use of Pfizer’s coronavirus vaccine on Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans. The injections could begin in a few days, depending on how quickly …
Read More »Rare, short-term allergic reactions to vaccines – health
Vaccines can sometimes cause allergic reactions, but they are usually rare and short-lived. British regulators are investigating reports of allergic reactions in two people who received the new Pfizer COVID-19 vaccine on Tuesday, the first day of a vaccination program. Meanwhile, they are telling people to skip the vaccine if …
Read More »Panel seeks more data on vaccines ahead of emergency approval
Written by Kaunain Sheriff M, Prabha Raghavan | New Delhi | Updated: December 10, 2020 7:08:31 am Pfizer, which received emergency clearance for the use of its Covid-19 vaccine in the UK, with the first doses delivered on Tuesday, had approached DCGI with a request that no clinical trials be …
Read More »Frontline staff, over 50, youth at risk
Written by Kaunain Sheriff M | New Delhi | Updated: December 9, 2020 10:03:07 am At the Serum Institute of India on Monday. (Photo: Reuters) One crore of health workers, two crore of frontline workers, including the police and armed forces, and around 27 crore of people over 50 and …
Read More »Four trial volunteers who received Pfizer’s COVID-19 vaccine developed Bell’s palsy, World News
When the UK began giving people the Pfizer-BioNTech vaccine, four people who received the Pfizer coronavirus vaccine in the company’s trial developed Bell’s palsy, a form of temporary facial paralysis, according to the regulators report. from USA Regulators at the Food and Drug Administration (FDA) said there was no clear …
Read More »3 Covid-19 Vaccine Developers Seek Emergency Use Approval In India
Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »With 26,567 Fresh Covid-19 Cases, India Records Lowest Daily Count in 5 Months; Counting crosses 97 lakh
India on Tuesday recorded the lowest number of cases in five months – 26,567 in the past 24 hours, government data shows. The daily case count fell amid preparations to start vaccinating high-risk groups. With new cases, the general coronavirus the tally has crossed 97 lakh-mark- 97,03,770, while the death …
Read More »Severely politicized, says Pfizer CEO Albert Bourla on Covid vaccine development
Pfizer CEO Albert Bourla said he understood concerns about the speed of vaccine development. Geneva: Pfizer Chief Executive Albert Bourla said Tuesday that he understood concerns about the speed at which drug companies have produced Covid-19 vaccines, but insisted no corners have been cut. When Britain became the first Western …
Read More »